Literature DB >> 21281783

The development of cutaneous neurofibromas.

Eeva-Mari Jouhilahti1, Sirkku Peltonen, Tom Callens, Elina Jokinen, Anthony M Heape, Ludwine Messiaen, Juha Peltonen.   

Abstract

Cutaneous neurofibromas are the hallmarks of neurofibromatosis type 1 (NF1). They are composed of multiple cell types, and traditionally they are believed to arise from small nerve tributaries of the skin. A key finding in the context of this view has been that subpopulations of tumor Schwann cells harbor biallelic inactivation of the NF1 gene (NF1(-/-)). In the present study, our aim was to clarify further the pathogenesis of cutaneous neurofibromas. First, we detected cells expressing multipotency-associated biomarkers in cutaneous neurofibromas. Second, we developed a method for isolating and expanding multipotent neurofibroma-derived precursor cells (NFPs) from dissociated human cutaneous neurofibromas and used it to analyze their growth and differentiation potential. In analogy to solitary cells resident in neurofibromas, NFPs were found to express nestin and had the potential to differentiate to, at least, Schwann cells, neurons, epithelial cells, and adipocytes. Mutation analysis of the NFPs revealed that their genotype was NF1(+/-). The results led us to speculate that the development of cutaneous neurofibromas includes the recruitment of multipotent NF1(+/-) precursor cells. These cells may be derived from the multipotent cells of the hair roots, which often are intimately associated with microscopic neurofibromas.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281783      PMCID: PMC3070575          DOI: 10.1016/j.ajpath.2010.10.041

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  A dermal niche for multipotent adult skin-derived precursor cells.

Authors:  Karl J L Fernandes; Ian A McKenzie; Pleasantine Mill; Kristen M Smith; Mahnaz Akhavan; Fanie Barnabé-Heider; Jeff Biernaskie; Adrienne Junek; Nao R Kobayashi; Jean G Toma; David R Kaplan; Patricia A Labosky; Victor Rafuse; Chi-Chung Hui; Freda D Miller
Journal:  Nat Cell Biol       Date:  2004-11       Impact factor: 28.824

2.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Authors:  Lu Q Le; Tracey Shipman; Dennis K Burns; Luis F Parada
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

3.  Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis.

Authors:  J Peltonen; S Jaakkola; M Lebwohl; S Renvall; L Risteli; I Virtanen; J Uitto
Journal:  Lab Invest       Date:  1988-12       Impact factor: 5.662

4.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

5.  Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures.

Authors:  S Jaakkola; J Peltonen; V Riccardi; M L Chu; J Uitto
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.

Authors:  E Serra; T Rosenbaum; U Winner; R Aledo; E Ars; X Estivill; H G Lenard; C Lázaro
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

7.  Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.

Authors:  L M Messiaen; T Callens; G Mortier; D Beysen; I Vandenbroucke; N Van Roy; F Speleman; A D Paepe
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

8.  Occult neurofibroma and increased S100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas.

Authors:  S L Karvonen; M Kallioinen; H Ylä-Outinen; M Pöyhönen; A Oikarinen; J Peltonen
Journal:  Arch Dermatol       Date:  2000-10

9.  Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells.

Authors:  Yasuyuki Amoh; Lingna Li; Meng Yang; A R Moossa; Kensei Katsuoka; Sheldon Penman; Robert M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

10.  Different types of benign nerve sheath tumors. Light microscopy, electron microscopy and autoradiography.

Authors:  H Lassmann; W Jurecka; G Lassmann; W Gebhart; H Matras; G Watzek
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-09-28
View more
  22 in total

1.  The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1 +/- or NF1 -/- genotype derived from human cutaneous neurofibromas.

Authors:  Paula Pennanen; Sirkku Peltonen; Roope A Kallionpää; Juha Peltonen
Journal:  Mol Cell Biochem       Date:  2017-11-28       Impact factor: 3.396

Review 2.  Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes.

Authors:  Fausto J Rodriguez; Constantine A Stratakis; D Gareth Evans
Journal:  Acta Neuropathol       Date:  2011-12-31       Impact factor: 17.088

3.  Robust surgical approach for cutaneous neurofibroma in neurofibromatosis type 1.

Authors:  Bahir H Chamseddin; La'Nette Hernandez; Dezehree Solorzano; Juan Vega; Lu Q Le
Journal:  JCI Insight       Date:  2019-04-30

4.  Runx1 contributes to neurofibromatosis type 1 neurofibroma formation.

Authors:  H Li; X Zhao; X Yan; W J Jessen; M-O Kim; E Dombi; P P Liu; G Huang; J Wu
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

Review 5.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

6.  From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.

Authors:  Rosalie E Ferner; Annette Bakker; Ype Elgersma; D Gareth R Evans; Marco Giovannini; Eric Legius; Alison Lloyd; Ludwine M Messiaen; Scott Plotkin; Karlyne M Reilly; Aaron Schindeler; Miriam J Smith; Nicole J Ullrich; Brigitte Widemann; Larry S Sherman
Journal:  Am J Med Genet A       Date:  2019-03-25       Impact factor: 2.802

7.  A novel mutation of the NF1 gene in a Chinese family with neurofibromatosis type 1.

Authors:  Qi He; Jingjing Jiang; Jiao Yang; Junjie Zeng; Huan Zhang; Zhengzhong Zhang
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

Review 8.  Advances in the treatment of neurofibromatosis-associated tumours.

Authors:  Andrew L Lin; David H Gutmann
Journal:  Nat Rev Clin Oncol       Date:  2013-08-13       Impact factor: 66.675

9.  Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.

Authors:  Gaku Tsuji; Ayako Takai-Yumine; Takahiro Kato; Masutaka Furue
Journal:  Cell Death Dis       Date:  2021-05-19       Impact factor: 8.469

10.  Skin-derived precursor cells as an in vitro modelling tool for the study of type 1 neurofibromatosis.

Authors:  Araika Gutiérrez-Rivera; Haizea Iribar; Anna Tuneu; Ander Izeta
Journal:  Stem Cells Int       Date:  2012-04-01       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.